 |
|
|
| |
HPTN 083: Efficacy of Pre-exposure Prophylaxis (PrEP) containing Long-acting injectable cabotegravir (CAB-LA) is maintained across regions and key populations
|
| |
| |
Download the PDF here
IAC 2020 Virtual: HPTN 083 FINAL RESULTS: Pre-exposure Prophylaxis containing long-acting injectable cabotegravir is safe and highly effective for cisgender men and transgender women who have sex with men - (07/08/20) Raphael J. Landovitz MD MSc on behalf of the HPTN 083 Study Team
IAC 2020 July 9 virtual
Beatriz Grinsztejn, MD
FIOCRUZ
https://events.ugovirtual.com/event/AIDS2020/en-us#!/Auditorium
|
| |
|
|
|
|
|
